2003•JAIDS Journal of Acquired Immune Deficiency SyndromesRequires access

The Interface of Perinatal HIV Prevention, Antiretroviral Drug Resistance, and Antiretroviral Treatment: What Do We Really Know?

Mary Glenn Fowler, Lynne Mofenson, Michelle S. McConnell

Open publisher page 20 citations

Abstract

Fowler, Mary Glenn MD, MPH; Mofenson, Lynne MD; McConnell, Michelle MD Author Information

About this research paper

What this paper is about

Fowler, Mary Glenn MD, MPH; Mofenson, Lynne MD; McConnell, Michelle MD Author Information

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Fowler, Mary Glenn MD, MPH; Mofenson, Lynne MD; McConnell, Michelle MD Author Information

Key concepts: Antiretroviral drug, Human immunodeficiency virus (HIV), Antiretroviral therapy, Antiretroviral treatment, Drug resistance, Medicine, Virology, Pediatrics

Back to paper search Browse research topics Original source

The Interface of Perinatal HIV Prevention, Antiretroviral Drug Resistance, and Antiretroviral Treatment: What Do We Really Know? — Research Paper | ScholarLens

The Interface of Perinatal HIV Prevention, Antiretroviral Drug Resistance, and Antiretroviral Treatment: What Do We Really Know?

About this research paper

What this paper is about

Why it matters

Key contribution

Method / approach

Main findings

Limitations

Applications

Available abstract

Related papers